Reference
Schulman KA, et al. Specialty Pharmaceuticals for Hyperlipidemia - Impact on Insurance Premiums. New England Journal of Medicine : 7 Oct 2015. Available from: URL: http://doi.org/10.1056/NEJMp1509863
Rights and permissions
About this article
Cite this article
New antihyperlipidaemics may impact US pricing models. PharmacoEcon Outcomes News 739, 4 (2015). https://doi.org/10.1007/s40274-015-2522-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2522-y